Christian Angermayer On His Continued Belief In The Psychedelic Sector and Atai Life Sciences Apr 4, 2023
Apeiron Founder Christian Angermayer Makes Follow-On Purchase Of Atai Life Sciences Shares Mar 30, 2023
atai Life Sciences Investor Christian Angermayer Addresses Recent Trial Results And Pipeline Outlook Jan 13, 2023
atai Life Sciences Investor Christian Angermayer On The Company’s Low Valuation And Late-Stage Pipeline Nov 16, 2022
atai Life Sciences: Unparalleled Diversification With 10 Psychedelic Compounds Going Into Clinical Trials In 2022 May 25, 2022
Trade To Black Podcast: Christian Angermayer Bullish On Psychedelic Sector And Life Extension Technology May 22, 2022
